Posted by: fuadelhibri on: May 2, 2011
Total of 2,784 infants vaccinated in TB efficacy trial evaluating MVA85A Study results expected to be available as early as mid-2012 ROCKVILLE, Md., Apr 28, 2011 Emergent BioSolutions Inc. (NYSE:EBS) announced today that its joint venture with the University of Oxford (Oxford), the Oxford-Emergent Tuberculosis Consortium (OETC), has vaccinated the last of the 2,784 infants [...]
